Ibnsina Pharma’s consolidated net profits jump 188.1% YoY in 2024
Updated 2/25/2025 10:13:00 AM
Arab Finance: Ibnsina Pharma generated consolidated net profits after tax and non-controlling interest valued at EGP 614.562 million in 2024, up by 188.15% from EGP 213.272 million in 2023, the financial results showed.
Net sales hiked to EGP 55.842 billion at the end of December 2024 from EGP 33.949 billion in 2023, while the earnings per share (EPS) increased to EGP 0.49 from EGP 0.17.
Regarding the standalone financials, the net profits after tax climbed to EGP 620.525 million last year from EGP 246.982 million in 2023.
Non-consolidated net sales reached EGP 55.657 billion in 2024, an annual rise from EGP 33.842 billion.
In the first nine months of 2024, the consolidated net profits after tax and non-controlling interest widened to EGP 406.513 million from EGP 174.037 million a year earlier.
Related News
